Insights: New US tariff plans for the pharmaceutical industry
The new US tariff plans for pharmaceuticals not only affect costs, but entire supply chains. The article shows what this means for pharmaceutical companies in Europe and their planning.
Interview: Excel works ... until it doesn't
Excel is still the central tool for planning in many companies. However, with increasing complexity, it is increasingly reaching its limits. In this interview, we talk about how to recognize this, why „working“ is not the same as „optimal“ and how planning is changing fundamentally today.
Insights: Scenario-based replanning
When demand, capacities or material availability change, Excel quickly reaches its limits in production planning. This article shows how pharmaceutical and chemical companies can set up new planning more reliably, quickly and comprehensibly.